scispace - formally typeset
M

Mark Coles

Researcher at University of Oxford

Publications -  146
Citations -  7300

Mark Coles is an academic researcher from University of Oxford. The author has contributed to research in topics: Population & Stromal cell. The author has an hindex of 42, co-authored 136 publications receiving 6123 citations. Previous affiliations of Mark Coles include John Radcliffe Hospital & University of York.

Papers
More filters
Journal ArticleDOI

Transgenic mice with hematopoietic and lymphoid specific expression of Cre.

TL;DR: Mouse lines expressing Cre recombinase in hematopoietic tissues using the vav regulatory elements, or in lymphoid cells using the hCD2 promoter and locus control region (LCR) are generated, which will be useful in generating tissue‐specific gene deletions within all the cells of hematoplastic or lymphoid tissues.
Journal ArticleDOI

The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development

TL;DR: Overexpression of E4bp4 was sufficient to increase NK cell production from hematopoietic progenitor cells and acted in a cell-intrinsic manner 'downstream' of the interleukin 15 receptor (IL-15R and through the transcription factor Id2.
Journal ArticleDOI

Tyrosine kinase receptor RET is a key regulator of Peyer’s Patch organogenesis

TL;DR: It is shown that the haematopoietic cells in the gut exhibit a random pattern of motility before aggregation into the primordia of Peyer’s patches, a major component of the gut-associated lymphoid tissue.
Journal ArticleDOI

A Zebrafish Compound Screen Reveals Modulation of Neutrophil Reverse Migration as an Anti-Inflammatory Mechanism

TL;DR: The authors used a transgenic zebrafish model of sterile tissue injury to screen potential factors involved in inflammation resolution and found that tanshinone IIA, which is derived from a Chinese medicinal herb, had proresolving activity by both inducing neutrophil apoptosis and promoting reverse migration of neutrophils.